Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001013596-12-000006)

Filing Details

Accession Number:: 0001013596-12-000006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-07 20:00:12
Reporting Period:: 2011-12-21

Filing Date:: 2012-09-07
Accepted Time:: 2012-09-07 20:00:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1402328	Sunshine Biopharma Inc	SBFM	Services-Management Consulting Services (8742)	205566275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1474684	N. Steve Slilaty	579 Rue Lajeunesse Laval A8 H7X 3K4	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-21	17,000,000	$0.00	34,109,194	No	4	C	Indirect	Owned by Advanomics Corporation, an entity contolled by Reporting Person.
Common Stock	Disposition	2012-09-04	2,591,500	$0.05	31,517,694	No	4	S	Indirect	Owned by Advanomics Corporation, an entity controlled by Reporting Person.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Owned by Advanomics Corporation, an entity contolled by Reporting Person.
No	4	S	Indirect	Owned by Advanomics Corporation, an entity controlled by Reporting Person.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2011-12-21	17,000,000	$0.00	17,000,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-10-15	2034-10-15	No	4	C	Indirect